Skip to main content
SpringerLink
Log in

Use of Proteins to Increase the Aqueous Solubility of Rifapentine

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Parenteral formulations of the poorly soluble antituberculosis antibiotic rifapentine were developed. Proteins (human serum albumin, succinylated gelatin, and sodium caseinate) were used to produce water-soluble forms of rifapentine by precipitation or homogenization. Ultrasonic homogenization gave the best results, i.e., stable colloidal suspensions with 9 – 10 mg of rifapentine per mL (practically 100 times greater than its water solubility). Dilution of the suspensions led to dissociation of the aggregates formed during the solubilization and formation of a clear solution. The particle size decreased to 10 – 20 nm, which corresponded to the particle size in a solution of the proteins at the same concentration. This would not cause embolization upon infusion of such water-soluble forms of rifapentine. The results indicated that the selected approach was promising for designing parenteral formulations of rifapentine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. P. G. Nielsen, Abstr. Pharm. Technol. Eur., 23(3), 1 – 4 (2010).

    Google Scholar 

  2. R. G. Strickley, Pharm. Res., 21(2), 201 – 230 (2004).

    Article  CAS  PubMed  Google Scholar 

  3. S. Katteboinaa, V. S. R. Chandrasekhar P., and S. Balaji, Int. J. PharmTech Res., 1(3), 682 – 694 (2009).

  4. P. Koshy, Pharm. Lett., 2(4), 65 – 76 (2010).

    CAS  Google Scholar 

  5. A. B. Nighute and S. B. Bhise, Int. J. PharmTech Res., 1(2), 142 – 148 (2009).

    CAS  Google Scholar 

  6. K. Kalra, S. Sharma, and D. A. Jain, Int. J. Pharm. Life Sci., 3(3), 1503 – 1506 (2012).

    CAS  Google Scholar 

  7. J. J. Schwegman, The Online Industry Standard; URL: http: //www.pharmaceuticalonline.com / doc / basic-cycle-developmenttechniques-for-0002 (2010).

  8. S. J. Lee, S. J. Choi, Y. Li, et al., J. Agric. Food Chem., 59(1), 415 – 427 (2011).

    Article  CAS  PubMed  Google Scholar 

  9. P. W. Caessens, H. H. De Jongh, W. Norde, et al., Biochim. Biophys. Acta, 1430(1), 73 – 83 (1999).

    Article  CAS  PubMed  Google Scholar 

  10. D. E. Graham and M. C. Phillips, J. Colloid Interface Sci., 80, 403 – 414 (1979).

    Article  Google Scholar 

  11. E. Bouyer, G. Mekhloufi, V. Rosilio, et al., Int. J. Pharm., 436(1 – 2), 359 – 378 (2012).

  12. T. Peters, Adv. Protein Chem., 37, 161 – 245 (1985).

    Article  CAS  PubMed  Google Scholar 

  13. J.-E. Chang, W. S. Shim, S. G. Yang, et al., Pharm. Res., 29(3), 795 – 805 (2012).

    Article  CAS  PubMed  Google Scholar 

  14. S. Jain, R. Mathur, M. Das, et al., Nanomedicine, 6(10), 1733 – 1754 (2011).

    Article  CAS  PubMed  Google Scholar 

  15. F. Kratz, J. Controlled Release, 132, No. 3, 171 – 183 (2008).

    Article  CAS  Google Scholar 

  16. S. Curry, Sojo Univ. Publ. Centre, 1 – 29 (2011).

  17. U. Kragh-Hansen, V. T. Chuang, and M. Otagiri, Biol. Pharm. Bull., 25(6), 695 – 704 (2002).

    Article  CAS  PubMed  Google Scholar 

  18. J.-D. Yang, S. X. Deng, Z. F. Liu, et al., Luminescence, 22(6), 556 – 566 (2007).

    Article  Google Scholar 

  19. C.-X. Wang, F.-F. Yan, Y.-X. Zhang, et al., J. Photochem. Photobiol., A, 192, 23 – 28 (2007).

  20. G. K. Saraogi, P. Gupta, U. D. Gupta, et al., Int. J. Pharm., 385(1 – 2), 143 – 149 (2010).

  21. B. Braun sharing expertise, Gelofusine, modified fluid gelatin, pp. 2 – 3.

  22. Y. D. Livney, A. Shapira, and Y. G. Assaraf, in: Abstracts of the 16 th International Conference on Bioencapsulation, Dublin (2008), pp. 1 – 4.

  23. Rifapetine, DrugBank electronic database; URL: http: //www.drugbank.ca / drugs / DB01201

  24. Rifapentine (Priftin), Selleckchem electronic catalog; URL: http: // www.selleckchem.com / products / Rifapentine-(Priftin).html

  25. S. Riva and L. G. Silvestri, Annu. Rev. Microbiol., 26, 199 – 224 (1972).

    Article  CAS  PubMed  Google Scholar 

  26. W. Wehrli and M. Staehelin, Bacteriol. Rev., 35(3), 290 – 309 (1971).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. W. Wehrli, F. Knusel, K. Schmid, et al., Proc. Natl. Acad. Sci. USA, 61(2), 667 – 673 (1968).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. I. M. Rosenthal, K. Williams, and S. Tyagi, Am. J. Respir. Crit. Care Med., 174(1), 94 – 101 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. V. Arioli, M. Berti, G. Carniti, et al., J. Antibiot., 34(8), 1026 – 1032 (1981).

    Article  CAS  PubMed  Google Scholar 

  30. N. Rastogi, K. S. Goh, M. Berchel, et al., J. Antimicrob. Chemother., 46(4), 565 – 570 (2000).

    Article  CAS  PubMed  Google Scholar 

  31. W. J. Burman, K. Gallicano, and C. Peloquin, Clin. Pharmacokinet., 40(5), 327 – 341 (2001).

    Article  CAS  PubMed  Google Scholar 

  32. R. Cricchio and V. Arioli, USA Pat. No. 4,002,752, Jan. 11, 1977; Espacenet, URL: http: // worldwide.espacenet.com/publicationDetails / biblio?DB=worldwide.espacenet.com&II=0&ND=3&adjacent=true&locale=enEP&FT=D&date=19770111&CC=US&NR=4002752A&KC=A

  33. E. Occelli, M. Nebuloni, and B. Cavalleri, WO Pat. 9,000,553, Jan. 25, 1990; Espacenet, URL: http: // worldwide.espacenet.com / publicationDetails / biblio?DB=worldwide.espacenet.com&II=1&ND3&adjacent=true&locale=enEP&FT=D&date=19900125&CC=WO&NR=9000553A1&KC=A1

  34. M. Nebuloni, E. Occelli, and B. Cavalleri, Int. Pat. 9,200,302, Jan. 9, 1992; Espacenet, URL: http: // worldwide.espacenet.com / publicationDetails / biblio?DB=worldwide.espacenet.com&II=3&ND=3&adjacent=true&locale=enEP&FT=D&date=19920109&CC=WO&NR=9200302A1&KC=A1

  35. S. A. Glantz, Primer of Biostatistics, McGraw-Hill, New York (1997) [Russian transl. by Yu. A. Danilov, Praktika, Moscow (1999), pp. 81 – 122, 323 – 365].

  36. Geliko brochure, Kosher gelatin: functional & nutritional properties, pp. 1 – 3.

  37. A. O. Elzoghby, W. S. A. El-Fotoh, and N. A. Elgindy, J. Controlled Release, 153(3), 206 – 216 (2011).

    Article  CAS  Google Scholar 

  38. Q. Fu, J. Sun, W. Zhang, et al., Recent Pat. Anti-cancer Drug Discovery, 4(3), 262 – 272 (2009).

  39. K. Paal, J. Muller, and L. Hegedus, Eur. J. Biochem., 268(7), 2187 – 2191 (2001).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nanosystem Research and Production Corporation, 13a Kolomenskii Proezd, Moscow, 115446, Russia

    K. P. Ostrovskii, N. S. Osipova, L. V. Vanchugova, E. V. Shipulo, O. O. Maksimenko & S. É. Gel’perina

  2. G. F. Gause Institute of New Antibiotics, 11 Bol’shaya Pirogovskaya St., Moscow, 119021, Russia

    É. R. Pereverzeva & I. D. Treshchalin

Authors
  1. K. P. Ostrovskii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. S. Osipova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. V. Vanchugova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. V. Shipulo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. É. R. Pereverzeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. D. Treshchalin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O. O. Maksimenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. É. Gel’perina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. P. Ostrovskii.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 50, No. 6, pp. 39 – 44, June, 2016.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ostrovskii, K.P., Osipova, N.S., Vanchugova, L.V. et al. Use of Proteins to Increase the Aqueous Solubility of Rifapentine. Pharm Chem J 50, 407–412 (2016). https://doi.org/10.1007/s11094-016-1460-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-016-1460-8

Keywords

Search

Navigation